Trials / Conditions / Blasts 5 Percent or More of Bone Marrow Nucleated Cells
Blasts 5 Percent or More of Bone Marrow Nucleated Cells
4 registered clinical trials studyying Blasts 5 Percent or More of Bone Marrow Nucleated Cells.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Withdrawn | Inotuzumab Ozogamicin and Vincristine Sulfate Liposome in Treating Patients With Relapsed or Refractory CD22+ NCT03851081 | Roswell Park Cancer Institute | Phase 1 / Phase 2 |
| Terminated | ADCT-602 in Treating Patients With Recurrent or Refractory B-cell Acute Lymphoblastic Leukemia NCT03698552 | M.D. Anderson Cancer Center | Phase 1 / Phase 2 |
| Terminated | EphB4-HSA Fusion Protein and Cytarabine /or Liposomal Vincristine in Patients With Recurrent or Refractory Acu NCT03519984 | University of Southern California | Phase 1 |
| Completed | CD19-Specific T-cells in Treating Patients With Advanced Lymphoid Malignancies NCT02529813 | M.D. Anderson Cancer Center | Phase 1 |